featured
CD4/CD8 T-Cell Selection Affects CAR T-Cell Potency and Toxicity
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial
J. Clin. Oncol 2020 Apr 14;[EPub Ahead of Print], NN Shah, SL Highfill, H Shalabi, B Yates, J Jin, PL Wolters, A Ombrello, SM Steinberg, S Martin, C Delbrook, L Hoffman, L Little, A Ponduri, H Qin, H Qureshi, A Dulau-Florea, D Salem, HW Wang, C Yuan, M Stetler-Stevenson, S Panch, M Tran, CL Mackall, DF Stroncek, TJ FryFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.